Are you passionate about advancing cancer research through innovative technologies? Leiden University’s Faculty of Science, in collaboration with the Leiden Academic Centre for Drug Research (LACDR), announces a prestigious opportunity for aspiring researchers: the PhD Position in the Oncode Accelerator Project. This scholarship is a part of the Oncode Accelerator, a groundbreaking initiative funded by the Dutch National Growth Fund (NGF), aimed at revolutionizing cancer therapy development.
The Oncode Accelerator Project, a collaboration involving more than 30 public and private partners, aims to accelerate the discovery and development of novel cancer therapies to address unmet medical needs. This specific position focuses on leveraging Artificial Intelligence (AI) methodologies within the Oncode Accelerator Artificial Intelligence Platform to expedite the identification and development of anti-cancer drugs. The successful candidate will engage in cutting-edge research, contributing to the multidisciplinary efforts aimed at bringing new treatments to cancer patients faster.
User Review
( votes)Leiden University is a renowned research university located in the Netherlands. It’s one of Europe’s oldest universities, founded in 1575. Known for its strong academic reputation, Leiden University offers a wide range of programs in various fields, including sciences, humanities, law, social sciences, and medicine. With a vibrant international community and a commitment to academic excellence, Leiden University provides students with opportunities for personal and intellectual growth.
Application Deadline: April 5th, 2024
Brief Description
- University or Organization: Leiden University
- Department: Leiden Academic Centre for Drug Research (LACDR)
- Course Level: PhD
- Award: Full-time appointment initially for one year, extendable up to four years
- Access Mode: Online
- Number of Awards: NA
- Nationality: International
- The award can be taken in the: Netherlands